![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 25602 |
FusionGeneSummary for OSMR_FGG |
![]() |
Fusion gene information | Fusion gene name: OSMR_FGG | Fusion gene ID: 25602 | Hgene | Tgene | Gene symbol | OSMR | FGG | Gene ID | 9180 | 2266 |
Gene name | oncostatin M receptor | fibrinogen gamma chain | |
Synonyms | IL-31R-beta|IL-31RB|OSMRB|PLCA1 | - | |
Cytomap | 5p13.1 | 4q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | oncostatin-M-specific receptor subunit betaIL-31 receptor subunit betaIL-31R subunit betainterleukin-31 receptor subunit betaoncostatin-M specific receptor beta subunit | fibrinogen gamma chainfibrinogen, gamma polypeptidetesticular tissue protein Li 70 | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q99650 | P02679 | |
Ensembl transtripts involved in fusion gene | ENST00000274276, ENST00000502536, | ENST00000404648, ENST00000405164, ENST00000336098, ENST00000407946, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 8 X 9 X 3=216 |
# samples | 3 | 14 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(14/216*10)=-0.625604485218502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: OSMR [Title/Abstract] AND FGG [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | OSMR | GO:0034097 | response to cytokine | 8999038 |
Tgene | FGG | GO:0007160 | cell-matrix adhesion | 10903502 |
Tgene | FGG | GO:0031639 | plasminogen activation | 16846481 |
Tgene | FGG | GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 8100742 |
Tgene | FGG | GO:0034622 | cellular protein-containing complex assembly | 8910396 |
Tgene | FGG | GO:0042730 | fibrinolysis | 16846481 |
Tgene | FGG | GO:0045907 | positive regulation of vasoconstriction | 15739255 |
Tgene | FGG | GO:0045921 | positive regulation of exocytosis | 19193866 |
Tgene | FGG | GO:0050714 | positive regulation of protein secretion | 19193866 |
Tgene | FGG | GO:0051592 | response to calcium ion | 6777381 |
Tgene | FGG | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 10903502|19193866 |
Tgene | FGG | GO:0070527 | platelet aggregation | 6281794 |
Tgene | FGG | GO:0072378 | blood coagulation, fibrin clot formation | 16846481 |
Tgene | FGG | GO:0090277 | positive regulation of peptide hormone secretion | 19193866 |
Tgene | FGG | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 10903502 |
Tgene | FGG | GO:2000352 | negative regulation of endothelial cell apoptotic process | 10903502 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AI133452 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-5UTR | ENST00000274276 | ENST00000404648 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
3UTR-intron | ENST00000274276 | ENST00000405164 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
3UTR-intron | ENST00000274276 | ENST00000336098 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
3UTR-intron | ENST00000274276 | ENST00000407946 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
intron-5UTR | ENST00000502536 | ENST00000404648 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
intron-intron | ENST00000502536 | ENST00000405164 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
intron-intron | ENST00000502536 | ENST00000336098 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
intron-intron | ENST00000502536 | ENST00000407946 | OSMR | chr5 | 38935546 | - | FGG | chr4 | 155533803 | - |
Top |
FusionProtFeatures for OSMR_FGG |
![]() |
Hgene | Tgene |
OSMR | FGG |
Associates with IL31RA to form the IL31 receptor. BindsIL31 to activate STAT3 and possibly STAT1 and STAT5. Capable oftransducing OSM-specific signaling events.{ECO:0000269|PubMed:15184896, ECO:0000269|PubMed:8999038}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for OSMR_FGG |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for OSMR_FGG |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for OSMR_FGG |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FGG | P02679 | DB00364 | Sucralfate | Fibrinogen gamma chain | small molecule | approved |
Top |
RelatedDiseases for OSMR_FGG |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | OSMR | C0268398 | Familial lichen amyloidosis | 2 | CTD_human;ORPHANET;UNIPROT |
Hgene | OSMR | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | OSMR | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Tgene | FGG | C0272350 | Dysfibrinogenemia, Congenital | 7 | ORPHANET;UNIPROT |
Tgene | FGG | C0022548 | Keloid | 1 | CTD_human |
Tgene | FGG | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | FGG | C2584774 | Congenital hypofibrinogenemia | 1 | ORPHANET;UNIPROT |